Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma

S A Rajasekaran1, W J Ball, N H Bander

  • 1Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095, USA.

Abstract

Insights

Clear-cell renal cell carcinoma (RCC) shows significantly reduced beta-subunit levels of Na,K-ATPase, impacting kidney function. This diminished Na,K-ATPase activity is linked to the aggressive RCC tumor phenotype.

Area of Science:

  • Nephrology
  • Oncology
  • Molecular Biology

Background:

  • Clear-cell renal cell carcinoma (RCC) is an aggressive kidney cancer subtype.
  • Na,K-ATPase is a vital kidney enzyme composed of alpha and beta subunits.
  • The specific role of the Na,K-ATPase beta-subunit in kidney function and cancer remains unclear.

Purpose of the Study:

  • To investigate the expression and activity of Na,K-ATPase subunits in clear-cell RCC.
  • To determine the correlation between Na,K-ATPase levels and the clear-cell RCC phenotype.

Main Methods:

  • Immunoblot analysis to quantify Na,K-ATPase alpha and beta-subunit protein levels in normal kidney and RCC tissues.
  • Immunofluorescence and confocal microscopy to assess subunit localization.
  • Spectrophotometric assay to measure Na,K-ATPase activity.

Main Results:

  • Clear-cell RCC tissues exhibited a significant reduction (95.6%) in Na,K-ATPase beta-subunit levels compared to normal kidney.
  • The alpha-subunit levels were generally maintained or increased in RCC.
  • Reduced beta-subunit expression correlated with decreased Na,K-ATPase activity and loss of epithelial morphology in RCC.

Conclusions:

  • The Na,K-ATPase beta-subunit may play a regulatory role in enzyme activity in vivo.
  • Diminished Na,K-ATPase activity, associated with reduced beta-subunit levels, is linked to the clear-cell RCC phenotype.
  • These findings highlight a potential mechanism underlying RCC development and progression.